Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03590769 · ClinicalTrials.gov registry record · Phase 1
Arterial Imaging of Inflammation and Resolution After Endovascular Surgery
A Phase 1 study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 1
- Development phase
- 9
- Enrollment target
NCT03590769 is a Phase 1 study that has completed, run by University of California, San Francisco. The registered enrollment target is 9 participants.
The verdict
NCT03590769, a Phase 1 study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 9 participants
- Enrollment target
Study Summary
This study evaluates the local inflammatory and resolution response of patients undergoing peripheral vascular intervention like an angioplasty of the superficial femoral artery (SFA) or popliteal artery, or stenting of the iliac artery or SFA, through the use of Positron emission tomography-magnetic resonance imaging (PET/MRI). PET/MRI will be performed prior to intervention, one day and one week after intervention.
Interventions
- DRUG 18F-FDG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2017-06-01 |
| Est. Completion | 2019-09-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03590769
The ClinicalTrials.gov registry entry for NCT03590769 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 18F-FDG is the first listed.
NCT03590769 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03590769 about?
NCT03590769 is a clinical study titled "Arterial Imaging of Inflammation and Resolution After Endovascular Surgery". This study evaluates the local inflammatory and resolution response of patients undergoing peripheral vascular intervention like an angioplasty of the superficial femoral artery (SFA) or popliteal artery, or stenting of the iliac artery or SFA, through the use of Positron emission tomography-magneti...
What is the current status of trial NCT03590769?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2017-06-01. Estimated completion is 2019-09-03.
What interventions are being tested in trial NCT03590769?
The interventions under investigation include: 18F-FDG (DRUG).
Who is sponsoring clinical trial NCT03590769?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.